Delivery Order 75N92020D00022-75N92B24F20004
Award Date 9/3/20
Potential Completion Date 9/2/25
Potential Value $65K
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order contract worth $247,444.82 to Illumina, Inc. to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing instruments. The contract has a completion date of September 2, 2025. Illumina is a manufacturer of genetic and genomic analysis instruments and...
- The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $196,882.44 contract is for the provision of various Illumina sequencing systems, consumables, and support services. Illumina has previously been awarded prime and subcontract awards by federal agencies...
- The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $161,151.43 contract will provide Illumina's sequencing systems, reagents, and support services to the agency's research programs in Bethesda, Maryland. Illumina has a history of providing similar products and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $249,229.80 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analytical instruments and reagents. The contract is for the provision of Illumina's sequencing systems, reagents, and associated products and services to support genomic research and diagnostics. This award...
- The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $197,834.87 contract provides Illumina's NextSeq 2000 and 1000/2000 sequencing reagents to support life science research and diagnostics. This award is not associated with a set-aside program. Illumina has a history...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 2000 sequencers. The $202,227.89 award has a completion date of September 2, 2025 and does not utilize any set-aside designations....
- This federal contract award to Illumina, Inc. for $902,700.00 is for the purchase of an ILLUMINA NOVASEQ 6000 SEQUENCING SYSTEM by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract was awarded on a firm fixed price basis with no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has previously received prime federal...
- This is a firm fixed price delivery order issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, to Illumina, Inc. The $101,668.72 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of sequencing and array-based analytical instruments and reagents, has previously been...
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $118,026.03 firm fixed price delivery order provides Illumina's NovaSeq 6000 sequencing reagents, Illumina DNA PCR-free sample preparation kits, and other sequencing consumables to support the agency's research and...
- The Department of Health and Human Services' National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price Delivery Order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment and reagents. The $146,891.73 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, and support services. This award...